Assessment of high-efficacy agonism in synthetic cannabinoid receptor agonists containing l-tert-leucinate

Key Points

• High-efficacy agonism was achieved with synthetic cannabinoid receptor agonists containing l-tert-leucinate, influencing receptor pathways.
• The analysis detailed measurable changes in receptor activity due to synthetic cannabinoid treatments, with implications for drug design.
• Observational analysis aimed to assess agonism levels in synthetic cannabinoid receptor interactions, fostering future developments.
• Findings support the potential for synthetic cannabinoid applications in therapeutics while emphasizing the need for further evaluations.